Form 4: Phibro CEO Jack Bendheim Granted 16,840 RSUs
Insider Stock Grant
Phibro Animal Health Corp's President and CEO, Jack Bendheim, was granted 16,840 restricted stock units, vesting over three years.
Summary
- Jack Bendheim, President and CEO, Director, and 10% Owner of Phibro Animal Health Corp (PAHC), was granted 16,840 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of Class A Common Stock.
- The RSUs vest in substantially equal installments on the first three anniversaries of August 1, 2025.
- Vesting is contingent on Mr. Bendheim's continued employment through the applicable vesting date.
- Following this transaction, Mr. Bendheim directly beneficially owns 76,320 shares of Class A Common Stock.
Sentiment
Score: 7
Explanation: The grant of Restricted Stock Units to the CEO is a positive sign of long-term incentive alignment, though it is a routine compensation event rather than a strategic announcement.
Positives
- The grant of 16,840 Restricted Stock Units (RSUs) to President and CEO Jack Bendheim aligns his long-term incentives with shareholder value creation.
- The three-year vesting schedule encourages continued leadership and commitment to the company's sustained performance.
Negatives
- None identified in this filing.
Risks
- Vesting of the granted Restricted Stock Units is subject to the Reporting Person's continued employment through the applicable vesting dates.
Future Outlook
The Restricted Stock Units are scheduled to vest in substantially equal installments on the first three anniversaries of August 1, 2025, contingent on continued employment.
Management Comments
- None explicitly stated in the filing beyond the transaction details.
Industry Context
This filing is a routine insider transaction report and does not provide broader industry context.
Comparison to Industry Standards
- Not applicable; this filing reports an individual insider transaction, not company performance metrics for industry comparison.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| NA | NA | NA | NA | None reported in this filing. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Authorization | A Power of Attorney was established, authorizing Judith Weinstein and Henry Ko to prepare and file Section 16 reports on behalf of Jack Bendheim, ensuring compliance with SEC reporting obligations. | 08/15/2025 | Enhances efficiency and compliance for insider reporting requirements. |
Legal Proceedings
- None reported in this filing.
Related Party Transactions
- Grant of Restricted Stock Units to Jack Bendheim, who is the President and CEO, Director, and a 10% Owner of Phibro Animal Health Corp, constitutes a related party transaction.
Stakeholder Impact
- Shareholders: The RSU grant aligns the CEO's long-term interests with shareholder value creation, as the value of the RSUs is tied to the company's stock performance.
Next Steps
- First vesting installment of RSUs expected on or around August 1, 2026.
- Subsequent vesting installments expected on or around August 1, 2027, and August 1, 2028.
Key Dates
| Date | Description |
|---|---|
| 08/01/2025 | Start date for the RSU vesting period. |
| 08/15/2025 | Date of the RSU grant transaction. |
| 08/19/2025 | Date the Form 4 was filed. |
Recommendation
holdThis Form 4 reports a routine executive compensation grant of Restricted Stock Units, which is a standard practice for aligning management incentives with long-term shareholder interests. It does not provide new information that would significantly alter the investment thesis or warrant a change in existing positions.
Keywords
Phibro Animal Health, PAHC, Jack Bendheim, RSU, Restricted Stock Units, Insider Transaction, Form 4, Executive Compensation, Stock Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.